Active Pharmaceutical Ingredients
| S.NO | NAME OF THE PRODUCT | CAS NO. | THERAPEUTIC USE | DMF STATUS | GMP CERTIFICATION |
|---|---|---|---|---|---|
| 1 | Atracurium Besylate BP/Ph.Eur./USP/IP | 64228-79-1 | Neuromuscular Blocking Agent | Available | WHO, WC |
| 2 | Betahistine Dihydrochloride BP/Ph.Eur./USP/IP | 5579-84-0 | Anti-Vertigo | Available | Available |
| 3 | Biperiden Hydrochloride BP/Ph.Eur./USP/IP | 1235-82-1 | Anti-Parkinsonian | DMF available | WHO |
| 4 | Bisoprolol Fumarate BP/Ph.Eur./USP/IP/JP | 104344-23-2 | Anti-Hypertensive | DMF available | WHO, WC |
| 5 | Cisatracurium Besylate BP/Ph.Eur./USP/CP | 96946-42-8 | Neuromuscular Blocking Agent | DMF available | Available |
| 6 | Deferasirox Ph.Eur./IP/IH | 201530-41-8 | Iron Chelator | DMF available | WHO |
| 7 | Fingolimod Hydrochloride IH | 162359-56-0 | Multiple Sclerosis Therapy | DMF available | Available |
| 8 | Mirabegron IH | 223673-61-8 | Overactive Bladder Therapy | DMF available | WHO |
| 9 | Noscapine BP/Ph.Eur./USP/CP/IP/JP | 128-62-1 | Anti-Tussive | DMF available | WHO, WC, PMDA, NMPA |
| 10 | Noscapine Hydrochloride BP/Ph.Eur./JP | 912-60-7 | Anti-Tussive | DMF available | WHO, WC, PMDA |
| 11 | Oseltamivir Phosphate BP/Ph.Eur./USP/IP/CP | 204255-11-8 | Anti-Viral (Influenza) | DMF available | WHO, WC |
| 12 | Papaverine Hydrochloride BP/Ph.Eur./USP/IP/JP/CP | 61-25-6 | Anti-Spasmodic | DMF available | WHO, WC, PMDA, NMPA |
| 13 | Podophyllum Resin BP | 9000-55-9 | Anti-Wart | DMF not available | Available |
| 14 | Podophyllotoxin IH | 518-28-5 | Anti-Wart | DMF not available | Available |
| 15 | Risedronate Sodium BP/Ph.Eur./USP/IP | 353228-19-0 | Anti-Osteoporotic | DMF available | WHO, WC |
| 16 | Rocuronium Bromide BP/Ph.Eur./USP/IP | 119302-91-9 | Neuromuscular Blocking Agent | DMF available | WHO, WC |
| 17 | Tetrabenazine IH | 58-46-8 | Anti-Chorea (Huntington's) | DMF available | WHO, WC |
Table Legend:
- WC = EU Written Confirmation (European regulatory acceptance)
- PMDA = Japan Pharmaceuticals and Medical Devices Agency (foreign manufacturer accreditation)
- NMPA = China National Medical Products Administration (foreign manufacturer accreditation)
NOTE:
- All transactions are carried out in conformity with Patent Laws applicable in the user country.
- Responsibility with respect to third party's Patent rights in a specific country lies exclusively with the buyer.
